Shenzhou Cell Investor Relations Activity Record Form (2023 Pharmaceutical Special Group Performance Briefing)
Shenzhou Cell Investor Relations Activity Record Form (May 16, 2024)
Announcement of Shenzhou Cell to participate in the 2023 Pharmaceutical Special Group Performance Briefing
Shenzhou Cell Investor Relations Activity Record Form (May 8, 2024)
CITIC Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Beijing Shenzhou Cell Biotechnology Group Co., Ltd.
Shenzhou Cell Investor Relations Activity Record Form (May 6, 2024)
Shenzhou Cell Investor Relations Activity Record Form (April 30, 2024)
Inspection opinions of CITIC Securities Co., Ltd. on the listing and circulation of restricted shares issued by Beijing Shenzhou Cell Biotechnology Group Co., Ltd. to specific targets
CITIC Securities Co., Ltd. report on the 2023 continuous supervision work site inspection report of Beijing Shenzhou Cell Biotechnology Group Co., Ltd.
Shenzhou Cell 2023 Audit Report
Special audit report on the summary table of the non-operating capital occupation of Shenzhou Cell and other related financial transactions
Shenzhou Cell 2023 Independent Director Debriefing Report (What)
Shenzhou Cell 2023 Internal Control Audit Report
Special opinion of the board of directors of Shenzhou Cell on the 2023 independence self-inspection situation of independent directors
Shenzhou Cell Evaluation Report on the Performance of Accounting Firms
Shenzhou Cell 2023 Independent Director Debriefing Report (Su Zhiguo)
Shenzhou Cell 2023 Independent Director Debriefing Report (Wang Xiaochuan)
Shenzhou Cell's announcement on the forecast for daily related transactions in 2024
Verification opinions of CITIC Securities Co., Ltd. on Beijing Shenzhou Cell Biotechnology Group Co., Ltd.'s 2024 application for a comprehensive credit line and guarantee
CITIC Securities Co., Ltd.'s inspection opinions on the expected daily transactions of Beijing Shenzhou Cell Biotechnology Group Co., Ltd. in 2024
No Data